Progenity (PROG) Announces New Patent for Single-Molecule Detection Technology

Go back to Progenity (PROG) Announces New Patent for Single-Molecule Detection Technology

Progenity Announces New Patent for Single-Molecule Detection Technology

December 2, 2021 6:30 AM UTC

SAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a new patent related to its single-molecule detection platform under development.

The USPTO has issued U.S. Patent No. 11,186,863 entitled, Methods, Systems, and Compositions for Counting Nucleic Acid Molecules. The issued claims cover methods for capturing, amplifying, and imaging single copies of target... More